AcelRx Pharmaceuticals GAAP EPS of -$0.07 beats by $0.09
Source: SeekingAlpha
2025-03-31 16:07:17 ET
More on AcelRx Pharmaceuticals
- Seeking Alpha’s Quant Rating on AcelRx Pharmaceuticals
- Historical earnings data for AcelRx Pharmaceuticals
- Financial information for AcelRx Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
AcelRx Pharmaceuticals GAAP EPS of -$0.07 beats by $0.09
Talphera Inc.
NASDAQ: TLPH
TLPH Trading
0.54% G/L:
$0.7997 Last:
138,015 Volume:
$0.81 Open:
TLPH Latest News
March 18, 2026 04:05:00 pm
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
March 02, 2026 08:30:00 am
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
November 12, 2025 04:05:00 pm
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 12, 2025 09:28:49 am
Spider Silk, Strong Earnings, and Biotech Resilience Define the Midweek Momentum
TLPH Stock Data
$39,152,079
25,309,023
0.41%
12
N/A
Pharmaceuticals
Healthcare
US
San Mateo
